← Back to Analyst Consensus 
MRK Buy
Merck & Co., Inc.
Current Price —
Implied Upside —
Analysts 35
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 6 reiterations from 6 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 26, 2026 | qwimj | maintain | — | — | — |
| Oct 12, 2026 | Citigroup | maintain | Neutral → Neutral | $145 | 54% |
| Oct 12, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | $145 | 55% |
| Oct 8, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| Oct 7, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 5, 2026 | JP Morgan | maintain | Overweight → Overweight | $165 | 55% |
| Sep 29, 2026 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $180 | 55% |
| Sep 10, 2026 | HSBC | maintain | Buy → Buy | $172 | 53% |
| Sep 9, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Sep 8, 2026 | Guggenheim | maintain | Buy → Buy | $170 | 52% |
| Sep 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | $170 | 54% |
| Aug 25, 2026 | Wolfe Research | maintain | Outperform → Outperform | $180 | 54% |
| Aug 25, 2026 | Argus Research | maintain | Buy → Buy | $170 | 54% |
| Aug 21, 2026 | Goldman Sachs | maintain | Buy → Buy | $160 | 54% |
| Aug 20, 2026 | BMO Capital | maintain | Outperform → Outperform | $170 | 53% |
| Aug 20, 2026 | UBS | maintain | Buy → Buy | $175 | 54% |
| Aug 20, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | $150 | 55% |
| Aug 20, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $179 | 54% |
| Aug 12, 2026 | Daiwa Capital | upgrade | Neutral → Outperform | $143 | 41% |
| Aug 11, 2026 | Argus Research | maintain | Buy → Buy | $145 | 54% |
| Aug 5, 2026 | Guggenheim | maintain | Buy → Buy | $146 | 52% |
| Jul 29, 2026 | Barclays | maintain | Overweight → Overweight | $150 | 53% |
| Jul 13, 2026 | JP Morgan | maintain | Overweight → Overweight | $140 | 55% |
| Jul 13, 2026 | BMO Capital | maintain | Outperform → Outperform | $142 | 53% |
| Jul 13, 2026 | Guggenheim | maintain | Buy → Buy | $145 | 52% |
| Jul 9, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $113 | 54% |
| Jul 8, 2026 | RBC Capital | reiterate | Outperform → Outperform | $142 | 55% |
| Jul 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | $150 | 54% |
| Jul 6, 2026 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $120 | 50% |
| Jun 30, 2026 | B of A Securities | maintain | Buy → Buy | $141 | 53% |
| Jun 30, 2026 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $155 | 55% |
| Jun 24, 2026 | CICC | initiate | — → Outperform | $138 | 59% |
| May 1, 2026 | Wells Fargo | maintain | Overweight → Overweight | $145 | 54% |
| Apr 13, 2026 | UBS | maintain | Buy → Buy | $145 | 54% |
| Apr 6, 2026 | JP Morgan | maintain | Overweight → Overweight | $135 | 55% |
| Mar 30, 2026 | RBC Capital | reiterate | Outperform → Outperform | $142 | 55% |
| Mar 20, 2026 | Citigroup | maintain | Neutral → Neutral | $125 | 54% |
| Mar 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | $150 | 54% |
| Feb 25, 2026 | RBC Capital | initiate | — → Outperform | $142 | 55% |
| Feb 20, 2026 | Barclays | initiate | — → Overweight | $140 | 53% |
| Feb 9, 2026 | Freedom Broker | maintain | Hold → Hold | $110 | 59% |
| Feb 6, 2026 | Guggenheim | maintain | Buy → Buy | $140 | 52% |
| Feb 4, 2026 | Citigroup | maintain | Neutral → Neutral | $120 | 54% |
| Feb 4, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | $120 | 50% |
| Feb 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | $135 | 54% |
| Jan 27, 2026 | Citigroup | maintain | Neutral → Neutral | $115 | 54% |
| Jan 20, 2026 | TD Cowen | maintain | Hold → Hold | $120 | 54% |
| Jan 8, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $135 | 54% |
| Jan 7, 2026 | UBS | maintain | Buy → Buy | $130 | 54% |
| Jan 7, 2026 | Citigroup | maintain | Neutral → Neutral | $110 | 54% |
Price Target Trend
Aug 23, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days